| Literature DB >> 23259000 |
Abdulsamad Alsalahi1, Mahmood Ameen Abdulla, Mohammed Al-Mamary, Mohamed Ibrahim Noordin, Siddig Ibrahim Abdelwahab, Aied M Alabsi, Abdrabuh Shwter, Mohammed A Alshawsh.
Abstract
Hepato- and nephrotoxicity of Khat consumption (Catha edulis Forskal) have been evoked. Therefore, this study was conducted to evaluate such possible hepatorenal toxicity in female and male Sprague-Dawley rats (SD rats) focusing primarily on liver and kidney. In addition, female and male rats were investigated separately. Accordingly, forty-eight SD-rats (100-120 g) were distributed randomly into four groups of males and female (n = 12). Normal controls (NCs) received distilled water, whereas test groups received 500 mg/kg (low dose (LD)), 1000 mg/kg (medium dose (MD)), or 2000 mg/kg (high dose (HD)) of crude extract of Catha edulis orally for 4 weeks. Then, physical, biochemical, hematological, and histological parameters were analyzed. Results in Khat-fed rats showed hepatic enlargement, abnormal findings in serum aspartate aminotransferase (AST), and alkaline phosphatase (ALP) of male and female SD-rats and serum albumin (A) and serum creatinine (Cr) of female as compared to controls. In addition, histopathological abnormalities confirmed hepatic and renal toxicities of Khat that were related to heavy Khat consumption. In summary, Khat could be associated with hepatic hypertrophy and hepatotoxicity in male and female SD-rats and nephrotoxicity only in female SD-rats.Entities:
Year: 2012 PMID: 23259000 PMCID: PMC3522130 DOI: 10.1155/2012/829401
Source DB: PubMed Journal: Evid Based Complement Alternat Med ISSN: 1741-427X Impact factor: 2.629
Body weight and relative liver weight of male and female SD rats.
| Dose (mg/kg) | BW (g) | ALW (g) | RLW (W/W %) | |||
|---|---|---|---|---|---|---|
| Male | Female | Male | Female | Male | Female | |
| NC (10 mL/kg) | 200.13 ± 12.30 | 159.13 ± 6.98 | 9.57 ± 0.59 | 5.22 ± 0.28 | 3.5 ± 0.2 | 2.67 ± 0.10 |
| LD (500 mg/kg) | 168.25 ± 9.54 | 143.79 ± 5.26 | 6.80 ± 0.71 | 5.87 ± 0.29 | 3.1 ± 0.2 | 3.35 ± 0.13* |
| MD (1000 mg/kg) | 169.54 ± 9.75 | 143.25 ± 4.73 | 7.23 ± 0.75 | 5.87 ± 0.27 | 3.2 ± 0.2 | 3.42 ± 0.16* |
| HD (2000 mg/kg) | 161.42 ± 8.40* | 141.08 ± 4.75 | 8.77 ± 0.64 | 7.00 ± 0.24* | 4.2 ± 0.2* | 4.17 ± 0.17* |
BW: body weight; ALW: absolute liver weight; RLW: relative liver weight; HD: high dose; MD: medium dose; LD: low dose; NC: normal control. The treated groups received different doses of crude extract of Khat except NC which received distilled water. The values were expressed as mean ± S.E.M. the symbol (*) denoted a significant difference at P < 0.05.
Liver function test of male and female SD rats.
| Dose (mg/kg) | ALP (IU/L) | ALT (IU/L) | AST (IU/L) | A (g/L) | TB (uM/L) | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Male | Female | Male | Female | Male | Female | Male | Female | Male | Female | |
| NC (10 mL/kg) | 155.50 ± 6.22 | 100.83 ± 13.10 | 35.33 ± 2.51 | 39.67 ± 2.47 | 127.67 ± 4.48 | 135.17 ± 5.33 | 12.33 ± 1.75 | 15.67 ± 0.49 | 1.5 | 1.0 |
| LD (500 mg/kg) | 147.67 ± 22.31 | 107.67 ± 3.68 | 28.33 ± 3.44 | 25.33 ± 2.14 | 120.00 ± 15.64 | 127.00 ± 4.62 | 11.50 ± 2.74 | 12.50 ± 0.56b∗ | 2.0* | 2.5 |
| MD (1000 mg/kg) | 146.00 ± 16.42 | 149.67 ± 18.70* | 27.17 ± 3.11 | 30.50 ± 1.52 | 118.33 ± 13.44 | 173.33 ± 10.85* | 9.50 ± 2.43 | 13.67 ± 0.71 | 2.0* | 2.5 |
| HD (2000 mg/kg) | 225.67 ± 19.71* | 158.67 ± 10.15* | 38.17 ± 1.56 | 31.50 ± 1.5 | 170.83 ± 6.30* | 180.17 ± 10b∗ | 14.00 ± 1.41 | 12.50 ± 0.72b∗ | 3.0* | 3.0 |
A: albumin; ALP: alkaline phosphatase; AST: aspartate aminotransferase; ALT: alanine aminotransferase; TB: total Bilirubin, HD: high dose; MD: medium dose; LD: low dose; NC: normal control. The treated groups received different doses of crude extract of khat except NC which received distilled water. The values were expressed as mean ± S.E.M. The symbol (*) denoted a significant difference P < 0.05, whereas ( b∗) denoted a significant difference at P ≤ 0.01.
Serum enzymes of male and female SD rats.
| Dose (mg/kg) | Male SD-rats | Female SD-rats | ||
|---|---|---|---|---|
| CK (IU/L) | AM (IU/L) | CK (IU/L) | AM (IU/L) | |
| NC (10 mL/kg) | 1708.00 ± 100.61 | 686.00 ± 48.34 | 1836.33 ± 332.42 | 524.67 ± 31.09 |
| LD (500 mg/kg) | 1564.83 ± 73.67 | 731.33 ± 28.59 | 1380.17 ± 108.49 | 599.67 ± 59.78 |
| MD (1000 mg/kg) | 1699.67 ± 76.16 | 691.17 ± 43.61 | 1928.33 ± 84.34 | 441.83 ± 29.15 |
| HD (2000 mg/kg) | 2105.33 ± 291.87 | 636.67 ± 45.66 | 1919.17 ± 105.68 | 593.17 ± 64.25 |
AM: amylase; CK: creatine kinase; HD: high dose; MD: medium dose; LD: low dose; NC: normal control. The treated groups received different doses of crude extract of Khat except NC which received distilled water. The values were expressed as mean ± S.E.M. No significant difference was noticed between groups and normal controls, P ≥ 0.05.
Renal function test of male SD-rats.
| Dose (mg/kg) | Cr (uM/L) | BUN (mM/L) | Na (mM/L) | K (mM/L) | Cl (mM/L) | CO2 (mM/L) |
|---|---|---|---|---|---|---|
| NC (10 mL/kg) | 39.17 ± 2.22 | 6.05 ± 0.56 | 143.00 ± 1.53 | 4.80 ± 0.24 | 104.67 ± 1.73 | 22.15 ± 0.41 |
| LD (500 mg/kg) | 26.67 ± 2.25* | 4.62 ± 0.31 | 133.67 ± 9.35 | 4.37 ± 0.35 | 103.67 ± 6.11 | 22.07 ± 1.93 |
| MD (1000 mg/kg) | 29.17 ± 3.01* | 4.25 ± 0.50* | 128.17 ± 9.73 | 4.30 ± 0.23 | 94.17 ± 6.59 | 23.50 ± 1.38 |
| HD (2000 mg/kg) | 27.17 ± 0.95* | 5.63 ± 0.25 | 142.83 ± 2.44 | 4.78 ± 0.16 | 101.17 ± 1.33 | 24.12 ± 0.78 |
Cr: creatinine; BUN: urea; Na: Sodium; K: potassium; Cl: chloride; CO2: carbon dioxide; HD: high dose; MD: medium dose; LD: low dose; NC: normal control. The treated groups received different doses of crude extract of Khat except NC which received distilled water. The values were expressed as mean ± S.E.M. The superscript (*) indicated a significant difference (P < 0.05).
Renal function test of female SD rats.
| Dose (mg/kg) | Cr (uM/L) | BUN (mM/L) | Na (mM/L) | K (mM/L) | Cl (mM/L) | CO2 (mM/L) |
|---|---|---|---|---|---|---|
| NC (10 mL/kg) | 26.17 ± 0.87 | 5.42 ± 0.23 | 137.50 ± 3.92 | 4.55 ± 0.16 | 98.83 ± 2.71 | 23.18 ± 1.53 |
| LD (500 mg/kg) | 33.50 ± 1.34a∗ | 3.97 ± 0.11 | 130.33 ± 2.64 | 4.63 ± 0.24 | 90.00 ± 2.73 | 19.83 ± 1.18 |
| MD (1000 mg/kg) | 33.17 ± 2.30b∗ | 4.72 ± 0.88 | 125.17 ± 9.27 | 3.98 ± 0.36 | 93.17 ± 9.46 | 20.02 ± 1.69 |
| HD (2000 mg/kg) | 28.67 ± 1.31 | 5.27 ± 0.51 | 126.83 ± 9.39 | 4.12 ± 0.22 | 91.17 ± 7.51 | 20.08 ± 2.06 |
Cr: creatinine; BUN: urea; Na: Sodium; K: potassium; Cl: chloride; CO2: carbon dioxide; HD: high dose; MD: medium dose; LD: low dose; NC: normal control. The treated groups received different doses of crude extract of Khat except NC which received distilled water. The values were expressed as mean ± S.E.M. The superscript (*) indicated a significant difference, whereas (a) and (b) denoted a significant difference at P < 0.05 and P ≤ 0.01, respectively.
Blood film profile of male SD-rats.
| Dose (mg/kg) | RBC (×1012/L) | WBC (×109/L) | PLT (×109/L) | HGB (g/L) | HCT (L/L) | MCV (fl) | MCH (pg) | MCHC (g/L) |
|---|---|---|---|---|---|---|---|---|
| NC (10 mL/kg) | 7.80 ± 0.17 | 7.48 ± 0.46 | 560.67 ± 97.02 | 151.67 ± 2.69 | 7.48 ± 0.46 | 64.67 ± 0.49 | 19.50 ± 0.15 | 303.33 ± 2.03 |
| LD (500 mg/kg) | 7.80 ± 0.07 | 9.98 ± 0.83 | 757.83 ± 30.83 | 158.17 ± 1.42 | 9.98 ± 0.83 | 64.67 ± 1.28 | 20.32 ± 0.25 | 312.17 ± 2.56* |
| MD (1000 mg/kg) | 7.59 ± 0.06 | 8.48 ± 0.67 | 770.83 ± 48.22 | 151.50 ± 1.28 | 8.48 ± 0.67 | 64.00 ± 0.56 | 19.88 ± 0.16 | 310.67 ± 1.80* |
| HD (2000 mg/kg) | 7.56 ± 0.17 | 9.23 ± 1.06 | 613.83 ± 34.22 | 151.83 ± 2.26 | 9.23 ± 1.06 | 64.67 ± 0.92 | 20.17 ± 0.31 | 308.00 ± 0.73 |
RBC: red blood cells; WBC: white blood cells; PLT: platelets; HGB: hemoglobin; HCT: hematocrit; MCV: mean corpuscular volume; MCH: mean corpuscular hemoglobin; MCHC: mean corpuscular hemoglobin concentration; HD: high dose; MD: medium dose; LD: low dose; NC: normal control. The treated groups received different doses of crude extract of khat except NC which received distilled water. The values were expressed as mean ± S.E.M. The superscript (*) indicated a significant difference, P < 0.05.
Blood film profile of female SD rats.
| Dose (mg/kg) | RBC (×1012/L) | WBC (×109/L) | PLT (×109/L) | HGB (g/L) | HCT (L/L) | MCV (fl) | MCH (pg) | MCHC (g/L) |
|---|---|---|---|---|---|---|---|---|
| NC (10 mL/kg) | 8.24 ± 0.14 | 7.10 ± 0.88 | 616.33 ± 52.67 | 155.00 ± 2.35 | 0.51 ± 0.009 | 61.167 ± 0.48 | 18.58 ± 0.15 | 304.00 ± 1.37 |
| LD (500 mg/kg) | 8.22 ± 0.21 | 8.10 ± 0.37 | 727.67 ± 43.90 | 157.67 ± 2.91 | 0.51 ± 0.011 | 62.83 ± 0.54 | 19.35 ± 0.21a∗ | 308.33 ± 1.78 |
| MD (1000 mg/kg) | 7.82 ± 0.21 | 7.95 ± 0.16 | 760.67 ± 16.41 | 161.17 ± 2.74 | 0.50 ± 0.009 | 62.67 ± 0.49 | 19.65 ± 0.21b∗ | 315.67 ± 0.49b∗ |
| HD (2000 mg/kg) | 7.65 ± 0.09 | 9.80 ± 0.67a∗ | 722.67 ± 51.85 | 152.50 ± 1.38 | 0.49 ± 0.005 | 63.67 ± 0.42b∗ | 19.97 ± 0.21b∗ | 315.67 ± 2.03b∗ |
RBC: red blood cells; WBC: white blood cells; PLT: platelets; HGB: hemoglobin; HCT: hematocrit; MCV: mean corpuscular volume; MCH: mean corpuscular hemoglobin; MCHC: mean corpuscular hemoglobin concentration; HD: high dose; MD: medium dose; LD: low dose; NC: normal control. The treated groups received different doses levels except NC, received distilled water. The values were expressed as mean ± S.E.M. The superscript (*) indicated a significant difference, whereas (a) and (b) denoted a significant difference at P < 0.05 and P ≤ 0.01, respectively.
Figure 1Effect of Khat on histological sections of liver and kidney of male and female rats. (a) Normal control of males with normal liver parenchyma, (b) low dose of males with normal liver parenchyma, (c) medium dose of males with normal liver parenchyma, (d) high dose of males with moderate necrotic lesions around the central vein, (e) normal control of females with normal liver parenchyma, (f) low dose of females with normal liver parenchyma, (g) medium dose of females with slight necrotic lesion around the central hepatic vein, (h) high dose of females with a moderate necrotic lesion around the central hepatic vein, (i) normal control of males with normal renal parenchyma, (j) low dose of males with normal renal parenchyma, (k) medium dose of males with normal renal parenchyma, (l) high dose of males with normal renal parenchyma, (m) normal control of females with normal renal parenchyma, (n) low dose of females with mild necrotic lesion in the renal parenchyma, (o) medium dose of females with moderate necrotic lesion in the renal parenchyma, (p) high dose of females with severe necrotic lesions in the renal parenchyma (H & E stain 20x).